Cartesian Therapeutics, Inc. financial data

Symbol
RNAC on Nasdaq
Location
Frederick, MD
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1113% % 205%
Debt-to-equity -2498% % -818%
Return On Equity 287% % 92%
Return On Assets -12% % 83%
Operating Margin -8387% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26,003,606 shares 2.3%
Common Stock, Shares, Outstanding 26,003,606 shares 8.8%
Entity Public Float $193,901,954 USD 51%
Common Stock, Value, Issued $3,000 USD 50%
Weighted Average Number of Shares Outstanding, Basic 26,002,892 shares 21%
Weighted Average Number of Shares Outstanding, Diluted 26,002,892 shares 21%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $1,091,000 USD 17%
Revenue from Contract with Customer, Excluding Assessed Tax $436,000 USD -101%
Research and Development Expense $54,651,000 USD -1.8%
General and Administrative Expense $30,358,000 USD -33%
Operating Income (Loss) $91,497,000 USD -71%
Net Income (Loss) Attributable to Parent $47,979,000 USD 80%
Earnings Per Share, Basic 5 USD/shares -22%
Earnings Per Share, Diluted 5 USD/shares -22%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $143,384,000 USD -35%
Accounts Receivable, after Allowance for Credit Loss, Current $722,000 USD -85%
Assets, Current $147,260,000 USD -36%
Property, Plant and Equipment, Net $12,394,000 USD 21%
Operating Lease, Right-of-Use Asset $4,972,000 USD -63%
Goodwill $48,163,000 USD 0%
Other Assets, Noncurrent $5,551,000 USD
Assets $372,675,000 USD -18%
Accounts Payable, Current $2,225,000 USD 330%
Employee-related Liabilities, Current $3,060,000 USD 72%
Accrued Liabilities, Current $7,702,000 USD -18%
Contract with Customer, Liability, Current $0 USD -100%
Liabilities, Current $13,803,000 USD -36%
Contract with Customer, Liability, Noncurrent $0 USD -100%
Deferred Income Tax Liabilities, Net $16,141,000 USD 1.8%
Operating Lease, Liability, Noncurrent $8,727,000 USD -27%
Liabilities $408,519,000 USD -10%
Accumulated Other Comprehensive Income (Loss), Net of Tax $4,587,000 USD 0.41%
Retained Earnings (Accumulated Deficit) $729,797,000 USD -7%
Stockholders' Equity Attributable to Parent $35,844,000 USD -4866%
Liabilities and Equity $372,675,000 USD -18%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $23,108,000 USD -45%
Net Cash Provided by (Used in) Financing Activities $8,025,000 USD -119%
Net Cash Provided by (Used in) Investing Activities $1,075,000 USD -79%
Common Stock, Shares Authorized 350,000,000 shares 0%
Common Stock, Shares, Issued 26,003,606 shares 8.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $32,176,000 USD -221%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $145,119,000 USD -34%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $247,867,000 USD 99%
Deferred Tax Assets, Gross $274,806,000 USD 80%
Operating Lease, Liability $12,603,000 USD -14%
Depreciation $2,300,000 USD 156%
Payments to Acquire Property, Plant, and Equipment $1,075,000 USD 79%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $47,960,000 USD 80%
Lessee, Operating Lease, Liability, to be Paid $15,912,000 USD -18%
Property, Plant and Equipment, Gross $16,518,000 USD -0.12%
Operating Lease, Liability, Current $3,876,000 USD 40%
Lessee, Operating Lease, Liability, to be Paid, Year Two $4,345,000 USD -4.3%
Lessee, Operating Lease, Liability, to be Paid, Year One $4,538,000 USD 2.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3,309,000 USD -32%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,314,000 USD -47%
Deferred Tax Assets, Operating Loss Carryforwards $44,062,000 USD 48%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 9,427,168 shares 0.49%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,409,000 USD -39%
Operating Lease, Payments $317,000 USD -58%
Additional Paid in Capital $698,537,000 USD 1.7%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $10,242,000 USD -54%
Interest Expense $2,025,000 USD -35%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%